Canada's DelMar Pharmaceuticals Inc. appointed Saiid Zarrabian as the full-time president and CEO of the company.
Zarrabian had been serving as the company's interim president and CEO since November 2017.
DelMar Pharmaceuticals develops therapies for treating cancer.
